136 studies found for:    ROP
Show Display Options
Rank Status Study
1 Active, not recruiting Bevacizumab Eliminates the Angiogenic Threat of Retinopathy of Prematurity
Condition: Retinopathy of Prematurity
Interventions: Drug: Bevacizumab;   Procedure: Conventional Laser for ROP
2 Completed Pain Response During Examination for Retinopathy of Prematurity
Condition: Retinopathy of Prematurity
Intervention: Behavioral: suck 12.5% dextrose in water 5 minutes before the procedure
3 Enrolling by invitation Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity
Conditions: Retinopathy of Prematurity;   Retinal Detachment;   Blindness
Interventions: Drug: ACULAR;   Drug: REFRESH TEARS;   Drug: placebo
4 Active, not recruiting Telemedicine Approaches to Evaluating Acute-phase ROP
Condition: Retinopathy of Prematurity
Intervention:
5 Withdrawn Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity (BLOCK-ROP)
Condition: Retinopathy of Prematurity
Intervention: Drug: Bevacizumab
6 Completed Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity
Conditions: Infant, Newborn;   Infant, Low Birth Weight;   Infant, Small for Gestational Age;   Infant, Premature;   Retinopathy of Prematurity;   Blindness
Interventions: Procedure: Supplemental Oxygen Management;   Procedure: Conventional Oxygen Management
7 Completed "Eye Protection After Mydriatic Use for ROP Screening: Impact on Vitals Signs and Pain Scores"
Condition: Light Sensitivity
Intervention: Behavioral: eye covers
8 Terminated Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity
Condition: Retinopathy of Prematurity
Intervention: Drug: Bevacizumab
9 Completed Safety and Efficacy of Propranolol in Newborns With Retinopathy of Prematurity
Condition: Retinopathy of Prematurity
Intervention: Drug: Propranolol
10 Not yet recruiting Inositol to Reduce Retinopathy of Prematurity
Condition: Retinopathy of Prematurity (ROP)
Intervention: Drug: myo-Inositol 5% Injection
11 Completed Integrated Treatment to Persons With Mental Disorders and Co-occurring Substance Use Disorders
Conditions: Anxiety Disorders;   Mood Disorders;   Substance Use Disorders
Interventions: Behavioral: Integrated mental health and substance use treatment;   Behavioral: Treatment as usual
12 Completed Time Outside Target Oxygen Saturation Range in Preterm Infants and Long Term Outcomes and Preterm Infants
Condition: Retinopathy of Prematurity
Intervention:
13 Recruiting Bevacizumab 0.500MG Intravitreal There Isn't Lower Than 0.625MG in the Treatment of ROP Type 1
Condition: Retinopathy of Prematurity
Intervention: Procedure: Injection of bevacizumab intravitreal (Avastin)
14 Completed Vascular Endothelial Growth Factor in Stage V ROP
Condition: Retinopathy of Prematurity
Intervention: Procedure: Open-Sky Vitrectomy
15 Temporarily not available Use of Pan-Vascular Endothelial Growth Factor Receptor (Pan-VEGF) Blockade for the Treatment of Retinopathy of Prematurity (ROP) (Compassionate Use BLOCK-ROP)
Condition: Retinopathy of Prematurity
Intervention: Drug: Bevacizumab (Avastin)
16 Completed Oral Propranolol Versus Placebo for Early Stages of Retinopathy of Prematurity: A Randomized and Prospective Study
Condition: Retinopathy of Prematurity
Interventions: Drug: propranolol;   Drug: sucrose 5%
17 Completed
Has Results
REQUIP (Ropinirole Hydrochloride) IR Long-Term Phase 4 Study
Conditions: Parkinson Disease;   Parkinson's Disease
Interventions: Drug: ROP;   Drug: ROP+L-Dopa
18 Withdrawn VEGF In Systemic Circulation Of ROP-infants
Condition: Retinopathy of Prematurity (ROP)
Intervention:
19 Recruiting Registry for Severe ROP and Treatment on Visual Outcomes
Condition: Retinopathy of Prematurity
Intervention:
20 Recruiting Efficacy and Safety of Intravitreal Bevacizumab for Threshold ROP.
Condition: Stage 2+ or Stage 3+ Retinopathy of Prematurity in Zone I or Zone II.
Intervention: Procedure: Intravitreal Bevacizumab

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years